Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Zeposia
Zeposia
Bristol Myers Squibb reports data from Phase III multiple sclerosis trial
Clinical Trials Arena
Fri, 03/1/24 - 11:39 am
Bristol Myers Squibb
clinical trials
Zeposia
MS
multiple sclerosis
Bristol Myers says it needs another year to hit target for new drugs
Reuters
Thu, 10/26/23 - 10:40 am
Bristol Myers Squibb
Reblozyl
Sotyktu
Zeposia
Pfizer takes aim at BMS' first-in-class Zeposia with FDA nod for ulcerative colitis drug Velsipity
Fierce Pharma
Fri, 10/13/23 - 10:35 am
Bristol Myers Squibb
Zeposia
Pfizer
Velsipity
etrasimod
ulcerative colitis
FDA
BMS' Zeposia and AbbVie's Skyrizi Shake Up First-Line Prescribing Patterns in the US Ulcerative Colitis and Crohn's Disease Markets, Spherix Reports
PR Newswire
Sun, 12/4/22 - 01:24 pm
Bristol Myers Squibb
AbbVie
Zeposia
Skyrizi
ulcerative colitis
Crohn's Disease
gastroentrologists
The first big test of Pfizer’s Arena buyout clears a PhIII in bid to catch up to Zeposia
Endpoints
Wed, 03/23/22 - 10:56 am
Pfizer
Zeposia
Bristol Myers Squibb
Arena Pharmaceuticals
etrasimod
Bristol Myers Squibb Just Got Some Great Regulatory News
Motley Fool
Tue, 11/2/21 - 10:45 am
Bristol Myers Squibb
Zeposia
Europe
ulcerative colitis
Ventyx nabs a $152M upsized IPO to challenge BMS' Zeposia—and a backer with intimate knowledge of its rival
Fierce Biotech
Fri, 10/22/21 - 12:04 pm
Ventyx Biosciences
IPOs
autoimmune disease
Bristol Myers Squibb
Zeposia
How Big Is Bristol Myers Squibb's Latest FDA Approval?
Motley Fool
Sun, 06/13/21 - 10:42 pm
Bristol Myers Squibb
Zeposia
ulcerative colitis
FDA
BMS Flying High in May With Opdivo, Zeposia FDA Approvals
BioSpace
Fri, 05/28/21 - 11:23 am
Bristol Myers Squibb
FDA
clinical trials
Opdivo
Zeposia
ozanimod
ulcerative colitis
Bristol Myers Squibb can grow through Revlimid generics, execs insist, pointing to key launches
Fierce Pharma
Thu, 02/4/21 - 08:15 pm
Bristol-Myers Squibb
generics
Revlimid
Zeposia
Reblozyl
Onureg
Bristol Myers Squibb turns in priority review voucher for supplemental indication on an old Celgene drug
Endpoints
Wed, 02/3/21 - 10:55 am
Bristol-Myers Squibb
Celgene
FDA
ulcerative colitis
priority review
Zeposia
Bristol Myers Squibb execs tout progress on Zeposia, Reblozyl and Onureg launches
Fierce Pharma
Fri, 11/6/20 - 12:38 am
Celgene
Bristol-Myers Squibb
Zeposia
Reblozyl
Onureg
Bristol Myers Squibb's Zeposia boosts remission rates over placebo in ulcerative colitis patients
Fierce Pharma
Sun, 10/11/20 - 10:29 pm
Bristol-Myers Squibb
Zeposia
ulcerative colitis
clinical trials
BMS' Recently Approved MS Drug Shows Promise in Ulcerative Colitis Study
BioSpace
Tue, 06/2/20 - 11:20 pm
Bristol-Myers Squibb
Zeposia
ozanimod
ulcerative colitis
Bristol Myers Squibb's Zeposia launches into crowded MS market
Fierce Pharma
Tue, 06/2/20 - 10:50 am
Bristol-Myers Squibb
Celgene
Zeposia
drug launches
MS
multiple sclerosis
FDA Approves Bristol Myers MS Drug, But Pandemic Will Delay Launch
Xconomy
Thu, 03/26/20 - 10:42 am
Bristol-Meyers Squibb
Celgene
M&A
ozanimod
MS
mutliple sclerosis
drug launches
FDA
COVID-19
Zeposia